Periscope Capital
DMIIR icon

Periscope Capital’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

Periscope Capital’s Portfolio DMIIR Stock Details DMIIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18K Hold
300,000
– – ﹤0.01% 460
2026
Q2 		$24K Hold
300,000
– – ﹤0.01% 422
2026
Q1 		$24K Buy
300,000
+50,000
+20% +$5.68K ﹤0.01% 375
2025
Q4 		$35K Buy
+250,000
New +$35.7K ﹤0.01% 290

Other funds holding DMIIR

Picton Mahoney Asset Management
Picton Mahoney Asset Management Toronto, Ontario, Canada $14.8B AUM 38.11% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return
Wealthspring Capital
Wealthspring Capital West Harrison, New York $447M AUM 5.09% 1-Year Est. Return
Commonwealth of Pennsylvania Public School Employees Retirement System
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $21.9B AUM 28.42% 1-Year Est. Return
Mint Tower Capital Management
Mint Tower Capital Management Amsterdam, Netherlands $589M AUM 6.02% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return

Periscope Capital's DMIIR Position: Q3 2026 in Review

Periscope Capital held its Drugs Made In America Acquisition II Corp Right (DMIIR) position steady in Q3 2026 at 300,000 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #460.

Periscope Capital first reported a position in DMIIR in Q4 2025 and has held it in 4 quarters since. The position peaked at $35K in Q4 2025. 9 funds tracked by Wall St. Rank hold DMIIR as of Q3 2026.

  • Periscope Capital held 300,000 shares of Drugs Made In America Acquisition II Corp Right worth $18K as of Q3 2026.
  • Periscope Capital left its Drugs Made In America Acquisition II Corp Right share count unchanged in Q3 2026.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of Periscope Capital's portfolio in Q3 2026, its #460 holding.
  • Periscope Capital first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 4 quarters since.
  • Periscope Capital's Drugs Made In America Acquisition II Corp Right position peaked at $35K in Q4 2025.
  • 9 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q3 2026.

Based on Periscope Capital's 13F filing for Q3 2026, filed 6 Nov 2026.